Platelet-lymphocyte ratio is a predictor of venous thromboembolism in cancer patients

Thrombosis Research

Volumn 136, Issue 2, 2015, Pages 212-215

  Yang, Wenjuan ^a   Liu, Ying ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Cancer patients; Platelet lymphocyte ratio; Predictor; Venous thromboembolism

Indexed keywords

CORTICOSTEROID;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIGESTIVE SYSTEM CANCER; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; LABORATORY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PLATELET LYMPHOCYTE RATIO; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; RISK; SOLID TUMOR; SURGICAL TECHNIQUE; UROGENITAL TRACT CANCER; VENOUS THROMBOEMBOLISM; BLOOD; LYMPHOCYTE; METABOLISM; MIDDLE AGED; NEOPLASM; THROMBOCYTE;

AGED; BLOOD PLATELETS; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; VENOUS THROMBOEMBOLISM;

EID: 84938552388     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.11.025     Document Type: Article

References (25)

1. A.A. Khorana Cancer-associated thrombosis: updates and controversies Hematology Am Soc Hematol Educ Program 2012 2012 626 630 10.1182/asheducation-2012.1.626
2. G.C. Connolly, L. Menapace, S. Safadjou, C.W. Francis, and A.A. Khorana Prevalence and Clinical Significance of Incidental and Clinically Suspected Venous Thromboembolism in Lung Cancer Patients Clin Lung Cancer 14 6 2013 713 718 10.1016/j.cllc.2013.06.003
3. A. Falanga, and L. Zacharski Deep vein thrombosis in cancer: the scale of the problem and approaches to management Ann Oncol 16 5 2005 696 701 10.1093/annonc/mdi165
4. A.A. Khorana, C.W. Francis, E. Culakova, N.M. Kuderer, and G.H. Lyman Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 3 2007 632 634 10.1111/j.1538-7836.2007.02374.x
5. G. Agnelli, G. Bolis, L. Capussotti, R.M. Scarpa, F. Tonelli, E. Bonizzoni, and et al. A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project Ann Surg 243 1 2006 89 95
6. E.M. Bakirci, S. Topcu, K. Kalkan, I.H. Tanboga, A. Borekci, S. Sevimli, and et al. The Role of the Nonspecific Inflammatory Markers in Determining the Anatomic Extent of Venous Thromboembolism Clin Appl Thromb Hemost 2013 10.1177/1076029613494469
7. J. Rak, J.L. Yu, J. Luyendyk, and N. Mackman Oncogenes, trousseau syndrome, and cancer-related changes in the coagulome of mice and humans Cancer Res 66 22 2006 10643 10646 10.1158/0008-5472.CAN-06-2350
8. H.C. Kwon, S.H. Kim, S.Y. Oh, S. Lee, J.H. Lee, H.J. Choi, and et al. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer Biomarkers 17 3 2012 216 222 10.3109/1354750X.2012.656705
9. V. Asher, J. Lee, A. Innamaa, and A. Bali Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer Clin Transl Oncol 13 7 2011 499 503 10.1007/s12094-011-0687-9
10. Z. Baranyai, M. Krzystanek, V. Josa, K. Dede, E. Agoston, A.M. Szasz, and et al. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer Thromb Haemost 111 3 2014 483 490 10.1160/TH13-08-0632
11. S. Krenn-Pilko, U. Langsenlehner, E.M. Thurner, T. Stojakovic, M. Pichler, A. Gerger, and et al. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients Br J Cancer 110 10 2014 2524 2530 10.1038/bjc.2014.163
12. P. Ferroni, S. Riondino, V. Formica, V. Cereda, L. Tosetto, F. La Farina, and et al. Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio Int J Cancer 2014 10.1002/ijc.29076 [n/a-n/a]
13. F.R. Balkwill, and A. Mantovani Cancer-related inflammation: common themes and therapeutic opportunities Semin Cancer Biol 22 1 2012 33 40 10.1016/j.semcancer.2011.12.005
14. J. Candido, and T. Hagemann Cancer-related inflammation J Clin Immunol 33 Suppl. 1 2013 S79 S84 10.1007/s10875-012-9847-0
15. E. Sierko, and M.Z. Wojtukiewicz Platelets and angiogenesis in malignancy Semin Thromb Hemost 30 1 2004 95 108 10.1055/s-2004-822974
16. A.A. Khorana, C.W. Francis, E. Culakova, and G.H. Lyman Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study Cancer 104 12 2005 2822 2829 10.1002/cncr.21496
17. R. Simanek, R. Vormittag, C. Ay, G. Alguel, D. Dunkler, I. Schwarzinger, and et al. High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) J Thromb Haemost 8 1 2010 114 120 10.1111/j.1538-7836.2009.03680.x
18. P.H. Gibson, B.H. Cuthbertson, B.L. Croal, D. Rae, H. El-Shafei, G. Gibson, and et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting Am J Cardiol 105 2 2010 186 191 10.1016/j.amjcard.2009.09.007
19. I. Ray-Coquard, C. Cropet, M. Van Glabbeke, C. Sebban, A. Le Cesne, I. Judson, and et al. Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas Cancer Res 69 13 2009 5383 5391 10.1158/0008-5472.CAN-08-3845
20. C.F. Lu, H.J. Yu, J.X. Hou, and J. Zhou Increased procoagulant activity of red blood cells in the presence of cisplatin Chin Med J (Engl) 121 18 2008 1775 1780
21. G.C. Connolly, and C.W. Francis Cancer-associated thrombosis Hematology Am Soc Hematol Educ Program 2013 2013 684 691 10.1182/asheducation-2013.1.684
22. G. Agnelli, and J.A. Caprini The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options J Surg Oncol 96 3 2007 265 272 10.1002/jso.20808
23. G.C. Connolly, and A.A. Khorana Risk stratification for cancer-associated venous thromboembolism Best Pract Res Clin Haematol 22 1 2009 35 47 10.1016/j.beha.2008.12.006
24. L.L. Swystun, L.Y. Shin, S. Beaudin, and P.C. Liaw Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes J Thromb Haemost 7 4 2009 619 626 10.1111/j.1538-7836.2009.03300.x
25. H. Jensvoll, K. Blix, S.K. Braekkan, and J.B. Hansen Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromso Study PLoS One 9 3 2014 e92011 10.1371/journal.pone.0092011